Hi, How Are You?
↻
Let's Get Started
Forgot Password?
Sign Up
EN
Home
Article
Events
All Events
Webinar
new!
Product & Disease
Product
Disease
Pharmacovigilance
Medical Calculator
new!
Education
MOOC
CDK
Multimedia
FAQ & Feedback
Discussions
About Us
Login
Register
Product
Profile
PRODUCTS
DISEASE
PHARMACOVIGILANCE
MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
EMEGRAN
BRANDED
Serotonin receptors of the 5-hydroxytryptamine (5-HT3) type are located peripherally at the vagus nerve endings and centrally in the chemoreceptor trigger zone of the postrema area.
Available at :
Share this article
Related
Articles
Low Vitamin D Levels Increase the Risk of Paclitaxel-Induced Peripheral Neuropathy
by dr. Esther Kristiningrum | 23 Nov 2023
Single-Dose or Two-Dose Palonosetron in Pediatric Patients with Multiple-Day Chemotherapy
by dr. Hastarita Lawrenti | 26 Oct 2023
Blood Transfusion, Here are the Benefits for Recipients and Donors
by dr. Vivian Keung | 15 Sep 2023
Update on the Recommendation for the Use of PARPi in Ovarian Cancer Patients
by dr. Hastarita Lawrenti | 10 Oct 2022
Comparison of Granisetron 1 mg vs. 3 mg on the Effects of Nausea, Vomiting, and Shivering
by dr. Laurencia Ardi | 15 Sep 2022
Thalidomide Reduces Oral Mucositis in Nasopharyngeal Carcinoma Patients with Concurrent Chemoradiotherapy
by dr. Hastarita Lawrenti | 27 Apr 2022
TPC Induction Chemotherapy for Advanced Locoregional Nasopharyngeal Cancer Patients
by dr. Hastarita Lawrenti | 12 Apr 2022
Chemotherapy for breast cancer patients during pandemic
by Dr. Hastarita | 23 Mar 2022
Addition of Capecitabine to Adjuvant Chemotherapy for Early Stage Breast Cancer
by dr. Hastarita Lawrenti | 04 Feb 2022
Tislelizumab Therapy plus Chemotherapy is Beneficial for Patients with Recurrent or Metastatic Nasopharyngeal Cancer
by dr. Hastarita Lawrenti | 19 Jan 2022
×
Subscribe Status
Generals
Articles
CPD/CME & CDK
Events & Webinar
SAVE